Atrium Biotechnologies Company Profile

10:55 EST 15th December 2018 | BioPortfolio

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing segments of the health and personal care markets which are benefiting from the trend towards healthy living as well as the ageing of the population. We market a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through our highly specialized sales and marketing network, in more than 35 countries, primarily in North America, Europe and Asia.


490 Boston Post Road
United States of America


Phone: 1-866-628-2355
Fax: 1-866-866-6661

News Articles [141 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

Atrium Medical to sell biosurgery business to SeCQure Surgical’s subsidiary

Atrium Medical stated that the sale is expected to close in the fourth quarter of this year, subject to customary closing conditions and the receipt of regulatory approvals. The post Atrium Medical t...

HJ Capital 1 to buy Atrium Medical's biosurgery business

Atrium Medical, a subsidiary of Getinge, has reached a deal to sell its soft tissue reinforcement devices-focused biosurgery  -More- 

Court Agrees with Atrium Health, Rejecting Attempt by Mednax to Disrupt Transition to New ...

CHARLOTTE, N.C., June 25, 2018/PRNewswire/ -- Atrium Health is pleased that the North Carolina Business Court rejected the request of Mednax, the Florida-based Read more...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Data breach at Atrium Health’s billing vendor affects 2.65M patients

Between September 22 and September 29, 2018, an unauthorized third party gained access to the databases of AccuDoc Solutions, Atrium Health’s billing vendor.

Atrium Ljungberg Widens its Financing Base

STOCKHOLM, Nov. 23, 2018 /PRNewswire/ -- (ATRLJ-B.ST, NASDAQ Stockholm) Atrium Ljungberg is widening its financing base by issuing its first bonds on the Norwegian capital Read more...

Atrium Health’s Billing Vendor Hacked, 2.65M Patients Affected

Rajiv Leventhal, Managing EditorThe personal health data of more than 2 million Atrium Health patients has been compromised following a hack on the organization’s third-party billing vendor, AccuDoc...

Drugs and Medications [0 Results]


PubMed Articles [90 Associated PubMed Articles listed on BioPortfolio]

Left upper pulmonary vein connected to the persistent left superior vena cava and the left atrium.

Persistent left superior vena cava (PLSVC) is the most common anomalous thoracic venous drainage. A PLSVC usually drains into the right atrium through a dilated coronary sinus. It is rare that a PLSVC...

A work flow to build and validate patient specific left atrium electrophysiology models from catheter measurements.

Biophysical models of the atrium provide a physically constrained framework for describing the current state of an atrium and allow predictions of how that atrium will respond to therapy. We propose a...

Giant Left Atrium in a 14 Month Old Child with Compression of Airways.

Giant left atrium (GLA) is a rare entity in pediatric population. GLA carries a significant mortality risks and once existence is established, it needs to be evaluated with intention to treat. We repo...

Agitated saline contrast echocardiography reveals cor triatriatum dexter.

We present the case of a 54-year-old man who had an unusual finding in contrast echocardiography with agitated saline. Partition of the right atrium in two compartments, an opacified and a non-opacifi...

Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.

Among the potential factors which may contribute to the development and perpetuation of atrial fibrillation, dysregulation of miRNAs has been suggested. Thus in this study, we have quantified the basa...

Clinical Trials [85 Associated Clinical Trials listed on BioPortfolio]

Child With Anomalous Drainage of IVC to Left Atrium

The purpose is to see if any conclusions can be drawn about the uncommon heart defect: anomalous drainage of the inferior vena cava to the left atrium.

Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium

The aim of the study is to compare levels of differnts types of microparticles circulating before and after percutaneous occluding of the left atrium by patients with atrial fibrillation a...

Non - Invasive Evaluation of the Left Atrium Anatomy and Function

The aim of the study is to evaluate the accuracy and reproducibility of the left atrium (LA) anatomy and function in different populations and in patients with atrial fibrillation who have...

Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis

This is a prospective, single center, safety and feasibility trial to evaluate the transplantation of the left atrium and pulmonary veins in patients with pulmonary vein stenosis. Consente...

Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement

This study evaluates the safety and efficiency of surgical prevention of atrial fibrillation in patients with valvular heart disease and left atrium enlargement

Companies [115 Associated Companies listed on BioPortfolio]

Atrium Biotechnologies

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing seg...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Atrium Medical Corporation

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in ...

Æterna Zentaris Inc

The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Atrium Biotechnologies" on BioPortfolio

We have published hundreds of Atrium Biotechnologies news stories on BioPortfolio along with dozens of Atrium Biotechnologies Clinical Trials and PubMed Articles about Atrium Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atrium Biotechnologies Companies in our database. You can also find out about relevant Atrium Biotechnologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Corporate Database Quicklinks

Searches Linking to this Company Record